AAAAAA
Results: 1-25/42
Authors:
AVILES A
NAMBO MJ
CUADRA I
DELGADO S
TALAVERA A
Citation: A. Aviles et al., TREATMENT AND PROGNOSIS IN PATIENTS WITH PRIMARY GASTRIC MALT LYMPHOMA, Cancer research, therapy & control, 5(4), 1998, pp. 291-294
Authors:
AVILES A
GARCIA EL
TALAVERA A
NAMBO MJ
HUERTAGUZMAN J
DIAZMAQUEO D
Citation: A. Aviles et al., INTERFERON-ALPHA-2B AND LOW-DOSES OF METHOTREXATE IN PATIENTS WITH ADVANCED-STAGE MYCOSIS-FUNGOIDES, Cancer research, therapy & control, 5(4), 1998, pp. 337-340
Authors:
AVILES A
DIAZMAQUEO JC
TALAVERA A
NAMBO MJ
GARCIA EL
Citation: A. Aviles et al., MAINTENANCE THERAPY WITH INTERFERON-ALPHA-2B IN HODGKINS-DISEASE, Leukemia & lymphoma, 30(5-6), 1998, pp. 651-656
Authors:
AVILES A
DELGADO S
Citation: A. Aviles et S. Delgado, PROSPECTIVE CLINICAL-TRIAL COMPARING CHEMOTHERAPY, RADIOTHERAPY AND COMBINED THERAPY IN THE TREATMENT OF EARLY-STAGE HODGKINS-DISEASE WITH BULKY DISEASE, Clinical and laboratory haematology, 20(2), 1998, pp. 95-99
Authors:
AVILES A
GARCIA EL
TALAVERA A
HUERTAGUZMAN J
DIAZMAQUEO JC
Citation: A. Aviles et al., INTERFERON ALFA2B (IFN) AND LOW-DOSES OF METHOTREXATE IN PATIENTS WITH REFRACTORY CUTANEOUS T-CELL LYMPHOMA, British Journal of Haematology, 102(1), 1998, pp. 242-242
Authors:
AVILES A
Citation: A. Aviles, THE ROLE OF INTERFERON AS MAINTENANCE THERAPY IN MALIGNANT-LYMPHOMA, Medical oncology, 14(3-4), 1997, pp. 153-157
Authors:
AVILES A
CALVA A
DIAZMAQUEO JC
TALAVERA A
HUERTAGUZMAN J
VASQUEZ E
Citation: A. Aviles et al., DOSE-ESCALATION OF EPIRUBICIN IN THE CEOP-BLEO REGIMEN - A CONTROLLEDCLINICAL-TRIAL COMPARING STANDARD DOSES FOR THE TREATMENT OF DIFFUSE LARGE-CELL LYMPHOMA, Leukemia & lymphoma, 25(3-4), 1997, pp. 319-325
Authors:
AVILES A
DIAZMAQUEO JC
TALAVERA A
GARCIA EL
GUZMAN R
NAMBO MJ
Citation: A. Aviles et al., BONE-MARROW PROTECTION WITH AMIFOSTINE IN THE TREATMENT OF HIGH-RISK MALIGNANT-LYMPHOMA, European journal of cancer, 33(8), 1997, pp. 1323-1325
Authors:
AVILES A
NAMBO MJ
TALAVERA A
GARCIA EL
HUERTAGUZMAN J
MAQUEO JCD
Citation: A. Aviles et al., EPIRUBICIN (CEOP-BLEO) VERSUS IDAURUBICIN (CIOP-BLEO) IN THE TREATMENT OF ELDERLY PATIENTS WITH AGGRESSIVE NON-HODGKINS-LYMPHOMA - DOSE-ESCALATION STUDIES, Anti-cancer drugs, 8(10), 1997, pp. 937-942
Authors:
DUJOVNY M
AVILES A
AGNER C
Citation: M. Dujovny et al., AN INNOVATIVE APPROACH FOR CRANIOPLASTY USING HYDROXYAPATITE CEMENT, Surgical neurology, 48(3), 1997, pp. 294-297
Authors:
DUJOVNY M
AVILES A
AGNER C
FERNANDEZ P
CHARBEL FT
Citation: M. Dujovny et al., CRANIOPLASTY - COSMETIC OR THERAPEUTIC, Surgical neurology, 47(3), 1997, pp. 238-241
Authors:
AVILES A
ROSAS A
CLETO S
DIAZ N
GARCIA EL
Citation: A. Aviles et al., DEXAMETHASONE, ALL-TRANS-RETINOIC ACID AND INTERFERON-ALPHA 2A (DAI REGIMEN) IN THE TREATMENT OF REFRACTORY MULTIPLE-MYELOMA (RMM), Blood, 90(10), 1997, pp. 4120-4120
Authors:
TALAVERA A
NERI N
AVILES A
DIAZMAGUEO JC
Citation: A. Talavera et al., TREATMENT OF ADVANCED MULTIPLE-MYELOMA (MM) - COMPARING MODIFIED CMOPAND CMD PLUS INTERFERON ALPHA-2B(IFN), Blood, 90(10), 1997, pp. 4145-4145
Authors:
AVILES A
TALAVERA A
NERI N
NAMBO MJ
DIAZMAQUEO JC
Citation: A. Aviles et al., INTENSIVE CHEMOTHERAPY AND GM-CSF AS HEMATOLOGICAL SUPPORT IN THE TREATMENT OF HIGH-RISK MALIGNANT-LYMPHOMA, Blood, 90(10), 1997, pp. 841-841
Authors:
AVILES A
GUZMAN R
GARCIA EL
DIAZMAQUEO JC
Citation: A. Aviles et al., BIOLOGICAL MODIFIERS (ETETRINATE AND INTERFERON-ALFA 2A) IN THE TREATMENT OF REFRACTORY CUTANEOUS T-CELL LYMPHOMA, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 11(1), 1996, pp. 21-24
Authors:
AVILES A
DUQUE G
TALAVERA A
GUZMAN R
Citation: A. Aviles et al., INTERFERON-ALPHA-2B AS MAINTENANCE THERAPY IN LOW-GRADE MALIGNANT-LYMPHOMA IMPROVES DURATION OF REMISSION AND SURVIVAL, Leukemia & lymphoma, 20(5-6), 1996, pp. 495-499
Authors:
AVILES A
DELGADO S
HUERTAGUZMAN J
Citation: A. Aviles et al., MARGINAL ZONE B-CELL LYMPHOMA OF THE PAROTID-GLANDS - RESULTS OF A RANDOMIZED TRIAL COMPARING RADIOTHERAPY TO COMBINED THERAPY, European journal of cancer. Part B, Oral oncology, 32B(6), 1996, pp. 420-422
Authors:
AVILES A
DELGADO S
RUIZ H
DELATORRE A
GUZMAN R
TALAVERA A
Citation: A. Aviles et al., TREATMENT OF NON-HODGKINS-LYMPHOMA OF WALDEYERS RING - RADIOTHERAPY VERSUS CHEMOTHERAPY VERSUS COMBINED THERAPY, European journal of cancer. Part B, Oral oncology, 32B(1), 1996, pp. 19-23
Authors:
AVILES A
GUZMAN R
GARCIA EL
TALAVERA A
DIAZMAQUEO JC
Citation: A. Aviles et al., RESULTS OF A RANDOMIZED TRIAL OF GRANULOCYTE-COLONY-STIMULATING FACTOR IN PATIENTS WITH INFECTION AND SEVERE GRANULOCYTOPENIA, Anti-cancer drugs, 7(4), 1996, pp. 392-397
Authors:
AVILES A
GUZMAN R
DELGADO S
NAMBO MJ
GARCIA EL
DIAZMAQUEO JC
Citation: A. Aviles et al., INTENSIVE BRIEF CHEMOTHERAPY WITH HEMATOPOIETIC GROWTH-FACTORS AS HEMATOLOGICAL SUPPORT AND ADJUVANT RADIOTHERAPY IMPROVE THE PROGNOSIS IN AGGRESSIVE MALIGNANT-LYMPHOMA, American journal of hematology, 52(4), 1996, pp. 275-280
Authors:
AVILES A
HUERTAGUZMAN J
DELGADO S
FERNANDEZ A
DIAZMAQUEO JC
Citation: A. Aviles et al., IMPROVED OUTCOME IN SOLITARY BONE PLASMACYTOMAS WITH COMBINED THERAPY, Hematological oncology, 14(3), 1996, pp. 111-117
Authors:
AVILES A
NAMBO MJ
ROSAS A
TALAVERA A
HUERTA J
Citation: A. Aviles et al., COMBINED SURGERY AND CHEMOTHERAPY FOR THE TREATMENT OF PRIMARY INTESTINAL MALIGNANT-LYMPHOMA, GI cancer, 1(1), 1995, pp. 45-48
Authors:
AVILES A
FERNANDEZ R
TALAVERA A
GUZMAN R
Citation: A. Aviles et al., THE ROLE OF G-CSF AS HEMATOLOGICAL SUPPORT AFTER MYELOABLATIVE CHEMOTHERAPY FOR REFRACTORY HODGKINS-DISEASE, Cancer research, therapy & control, 4(4), 1995, pp. 241-245
Authors:
AVILES A
ROSAS A
TALAVERA A
NAMBO MJ
Citation: A. Aviles et al., USE OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR IN THE TREATMENT OF INFECTION AND SEVERE GRANULOCYTOPENIA, Cancer research, therapy & control, 4(3), 1995, pp. 157-161
Authors:
AVILES A
TALAVERA A
GUZMAN R
CUADRA I
Citation: A. Aviles et al., TREATMENT OF REFRACTORY LOW-GRADE LYMPHOMA WITH CHLORAMBUCIL ALTERNATING WITH INTERFERON AND RADIOTHERAPY, Cancer biotherapy, 10(4), 1995, pp. 273-277